Nature’s Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results
- Fourth Quarter GAAP Net Income More Than Triples to $9 Million, Adjusted EBITDA up 21% to $9.7 Million -LEHI,...
Month: March 2024
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on...
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
Minim Announces Merger Agreement with e2Companies
MANCHESTER, N.H., March 12, 2024 (GLOBE NEWSWIRE) -- Minim, Inc. (“Minim”) (NASDAQ: MINM) today announced that it has entered into...
Luna Innovations to Delay Release of Fourth Quarter and Full Year 2023 Financial Results
Contacts Investor Contact: Allison Woody Luna Innovations Incorporated Phone: 540.769.8465 Email: woodya@lunainc.com Media Contact: Chris Kittredge/Stephen Pettibone FGS Global Email:...
Bimbo Bakeries USA Commences Multi-Site Microgrid Energy System at Six California Bakeries
Microgrid System Developed as Part of Conservation Plan Through Partnership with GreenStruxureHORSHAM, Pa., March 12, 2024 (GLOBE NEWSWIRE) -- Bimbo...
Keurig Dr Pepper to Webcast 2024 Strategy Review and Investor Update on March 19
BURLINGTON, Mass. and FRISCO, Texas, March 12, 2024 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced that it will...
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
DUBLIN, March 12, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a virtual R&D Day, Tuesday, March 19,...
IGI Declares Extraordinary Cash Dividend and Regular Ordinary Common Share Dividend
Contacts Investors: Robin Sidders, Head of Investor Relations M: + 44 (0) 7384 514785 Email: robin.sidders@iginsure.com Media: Aaida Abu Jaber,...
Ichor Holdings, Ltd. Announces Public Offering of Ordinary Shares
Contacts Greg Swyt, CFO 510-897-5200 Claire McAdams, IR & Strategic Initiatives 530-265-9899 IR@ichorsystems.com Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader...
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
SAN DIEGO, March 12, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company,...
Fathom Holdings Establishes Verus Title Elite – A Strategic Joint Venture with Fathom Realty Top Producers in Texas
CARY, N.C., March 12, 2024 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM) ("Fathom" or the "Company"), a national, technology-driven, end-to-end real...
Domo Receives Five Dresner Advisory Services 2023 Technology Innovation Awards
This marks Domo’s seventh consecutive year as a multiple-category winner Contacts Cynthia Cowen PR@domo.com Today Domo (Nasdaq: DOMO) announced it...
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
NASHVILLE, Tenn., March 12, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for...
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative...
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
Paltusotine Treatment Demonstrated Rapid and Sustained Reductions in Frequency and Severity of Flushing Episodes and Bowel MovementsPaltusotine was Generally Well-Tolerated...
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 -- Partner Programs...
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell,...
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance
Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4%Company improves full-year 2023 Net Loss by $126.2...
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
Grew practitioner network to over 7,100 from 6,400 in 2022 Launched BioteRx, our new hormone and therapeutic wellness offerings Enhancing...
Allbirds Reports Fourth Quarter and Full Year 2023 Financial Results; Achieves Q4 Financial Guidance Targets
Allbirds COO Joe Vernachio Appointed CEO as Company Accelerates Strategic Transformation PlanCompany Provides 2024 OutlookRead more at globenewswire.com
Aware Reports Fourth Quarter Financial Results
Full Year Total Revenue Grew 14% to $18.2 Million, Marking Highest Level Since 2016Annual Recurring Revenue (ARR) increased 23% to...
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
SAN FRANCISCO, Calif. and WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology...
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
SOUTH SAN FRANCISCO, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical...
reAlpha Tech Corp. Announces Financial Results for the Transition Period ended December 31, 2023 and Provides Business Update
Contacts Investor Relations Contact investorrelations@realpha.com reAlpha Tech Corp. (“reAlpha,” “Company,” “us,” “we” or “our”) (Nasdaq: AIRE), a real estate technology...
Quickbase and Aeries Technology Enter Strategic Partnership to Enhance Global Technology and Innovation
Read more at globenewswire.com
AdTheorent Holding Company, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results
Fourth quarter revenue increased 15.2%Exceeded fourth quarter and full-year guidanceNEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- AdTheorent Holding Company,...
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
CHARLOTTESVILLE, Va., March 12, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel...
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
MINNEAPOLIS, March 12, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for...
Rare Element Resources Announces Results of Oversubscribed Rights Offering of Common Shares
Contacts Wayne Rich Chief Financial Officer +1-720-278-2460 wrich@rareelementresources.com Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased...
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
Westport reporte la publication de ses résultats financiers audités pour le quatrième trimestre et l’exercice 2023 au 25 mars 2024, après la clôture du marché
VANCOUVER, Colombie-Britannique, 12 mars 2024 /PRNewswire/ -- Westport Fuel Systems Inc. (TSX: WPRT) (NASDAQ: WPRT) (« Westport" ou « le société ») annonce qu'en considération de l'annonce faite...
Westrock Coffee Company Reports Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
LITTLE ROCK, Ark., March 12, 2024 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today...
voxeljet AG Accelerates Strategic Realignment and Announces its Plan to (i) Voluntarily Delist its ADSs from NASDAQ and (ii) Deregister its ADSs
Contacts Investors and Media Johannes Pesch Director Business Development & Investor Relations johannes.pesch@voxeljet.de Office: +49 821 7483172 voxeljet AG (NASDAQ:...
Venus Concept Launches “NEXThetics” Program
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical...
Veritone Reports Fourth Quarter and Fiscal Year 2023 Results
– Fiscal Year 2023 Revenue of $127.6 Million, in line with previously stated guidance – – Q4 Total Revenue and...
Usio’s Payments Technology Giving Sports Clubs a ‘Boost’
Integration of Usio’s Innovative Payment Technology is Key to BoosterHub’s Revolutionization of Sports Clubs Operation Proprietary PayFac-in-a-Box Payment Technology Powering...
Interface Declares Regular Quarterly Dividend
Contacts Christine Needles Global Corporate Communications Christine.Needles@interface.com +1 404-491-4660 Interface, Inc. (Nasdaq: TILE), the global flooring solutions company, today announced...
TransAct Technologies Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results
2023 Fourth Quarter Net Sales of $13.3 Million, down 26% on a Year-Over-Year Basis Quarterly Food Service Technology (“FST”) Sales...
Latham Group, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
Full Year 2023 Sales Outperformed the U.S. In-Ground Pool Market in 2023 Driven by Continued Fiberglass ConversionSubstantially Reduced Cost Structure...